SCHEMBL8770926

SCHEMBL8770926

COC(=O)CC(O)c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
GAA P10253 1/20 0.47
AOC3 Q16853 1/20 0.46
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
CNR2 P34972 1/20 0.43
PTGS2 P35354 1/20 0.43
BRD4 O60885 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
FFAR2 O15552 1/20 0.41
GABBR2 O75899 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
NFKB1 P19838 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29697542 1.00 L3MBTL1 (0.47) L3MBTL1GAAAOC3MAPTRAB9A
SCHEMBL14042112 0.84 TAAR1 (0.52) MAPTRAB9ALMNANFKB1BLM
SCHEMBL28827835 0.84 MAPT (0.47) L3MBTL1MAPTRAB9ALMNA
SCHEMBL3519792 0.84 LMNA (0.50) L3MBTL1MAPTRAB9ACNR2PTGS2
SCHEMBL13506383 0.84 GABBR2 (0.50) L3MBTL1MAPTRAB9ACNR2PTGS2
SCHEMBL4484678 0.84 TAAR1 (0.52) MAPTRAB9ALMNANFKB1BLM
SCHEMBL4486192 0.84 TAAR1 (0.52) MAPTRAB9ALMNANFKB1BLM
SCHEMBL1504155 0.83 ALDH1A1 (0.44) L3MBTL1GAAAOC3MAPTRAB9A
SCHEMBL9266677 0.83 GAA (0.51) L3MBTL1GAAAOC3MAPTCNR2
SCHEMBL30935351 0.83 ALDH1A1 (0.44) L3MBTL1GAAAOC3MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105039436-A Method for producing (S)-chlorobenzene methyl propionate through cells UNIV QINGDAO SCIENCE & TECHNOLOGY 2015-11-11 CN claimed
US-10906860-B2 Method for synthesizing chiral beta-hydroxy acid ester compound WENZHOU UNIVERSITY (CN) 2021-02-02 US disclosed
US-10906860-B2 Method for synthesizing chiral beta-hydroxy acid ester compound WENZHOU UNIVERSITY (CN) 2021-02-02 US disclosed
CN-109734600-B Synthesis method of chiral beta-hydroxy acid ester compound 温州大学 2020-09-15 CN disclosed
US-20200190013-A1 METHOD FOR SYNTHESIZING CHIRAL BETA-HYDROXY ACID ESTER COMPOUND WENZHOU UNIVERSITY (CN) 2020-06-18 US disclosed
US-20200190013-A1 METHOD FOR SYNTHESIZING CHIRAL BETA-HYDROXY ACID ESTER COMPOUND WENZHOU UNIVERSITY (CN) 2020-06-18 US disclosed
CN-109734600-A A kind of synthetic method of chiral beta carboxylic acid ester type compound 温州大学 2019-05-10 CN disclosed
CN-105039436-A Method for producing (S)-chlorobenzene methyl propionate through cells UNIV QINGDAO SCIENCE & TECHNOLOGY 2015-11-11 CN disclosed
EP-0451668-B1 Process for the production of optically active alkyl 3-aryl-3-hydroxypropionates CHISSO CORP (JP) 1997-08-13 EP disclosed
US-5202457-A Enzyme catalyzed transesterification, resolution of optical active alkyl 3-aryl-3-hydroxypropionate CHISSO CORPORATION (JP) 1993-04-13 US disclosed
EP-0451668-A2 Optically active alkyl 3-aryl-3-hydroxypropionates and a method for producing thereof CHISSO CORPORATION (JP) 1991-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190013-A1 METHOD FOR SYNTHESIZING CHIRAL BETA-HYDROXY ACID ESTER COMPOUND HSD11B1, HACL2, HAAO L3MBTL1 3381/4885GAA 327/4885AOC3 1093/4885
US-10906860-B2 Method for synthesizing chiral beta-hydroxy acid ester compound HSD11B1, HACL2, HAAO L3MBTL1 3381/4885GAA 327/4885AOC3 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.